172 related articles for article (PubMed ID: 35734585)
1. Radiomic Signatures for Predicting Receptor Status in Breast Cancer Brain Metastases.
Luo X; Xie H; Yang Y; Zhang C; Zhang Y; Li Y; Yang Q; Wang D; Luo Y; Mai Z; Xie C; Yin S
Front Oncol; 2022; 12():878388. PubMed ID: 35734585
[TBL] [Abstract][Full Text] [Related]
2. Radiomic Signatures for Predicting
Zheng L; Xie H; Luo X; Yang Y; Zhang Y; Li Y; Yin S; Li H; Xie C
Front Oncol; 2022; 12():931812. PubMed ID: 35912248
[TBL] [Abstract][Full Text] [Related]
3. Multiregional Radiomic Signatures Based on Functional Parametric Maps from DCE-MRI for Preoperative Identification of Estrogen Receptor and Progesterone Receptor Status in Breast Cancer.
Zhong S; Wang F; Wang Z; Zhou M; Li C; Yin J
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292247
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance.
Kotecha R; Tonse R; Rubens M; McDermott MW; Odia Y; Appel H; Mehta MP
Neurooncol Adv; 2021; 3(1):vdab010. PubMed ID: 33898990
[TBL] [Abstract][Full Text] [Related]
5. Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival.
Sperduto PW; Mesko S; Li J; Cagney D; Aizer A; Lin NU; Nesbit E; Kruser TJ; Chan J; Braunstein S; Lee J; Kirkpatrick JP; Breen W; Brown PD; Shi D; Shih HA; Soliman H; Sahgal A; Shanley R; Sperduto W; Lou E; Everett A; Boggs DH; Masucci L; Roberge D; Remick J; Plichta K; Buatti JM; Jain S; Gaspar LE; Wu CC; Wang TJC; Bryant J; Chuong M; Yu J; Chiang V; Nakano T; Aoyama H; Mehta MP
Neuro Oncol; 2020 Sep; 22(9):1359-1367. PubMed ID: 32034917
[TBL] [Abstract][Full Text] [Related]
6. Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C
J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.
Shen Q; Sahin AA; Hess KR; Suki D; Aldape KD; Sawaya R; Ibrahim NK
Oncologist; 2015 May; 20(5):466-73. PubMed ID: 25802405
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in the expression of receptors in the human breast cancer metastasized to the brain.
Rao PS; Labhart M; Mayhew SL; Thirumala S; Rao US
Tumour Biol; 2014 Jul; 35(7):7267-73. PubMed ID: 24777335
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
11. A Radiomics-Based Model for Potentially More Accurate Identification of Subtypes of Breast Cancer Brain Metastases.
Cho S; Joo B; Park M; Ahn SJ; Suh SH; Park YW; Ahn SS; Lee SK
Yonsei Med J; 2023 Sep; 64(9):573-580. PubMed ID: 37634634
[TBL] [Abstract][Full Text] [Related]
12. Radiogenomic association of deep MR imaging features with genomic profiles and clinical characteristics in breast cancer.
Liu Q; Hu P
Biomark Res; 2023 Jan; 11(1):9. PubMed ID: 36694221
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
15. Discordant and Converting Receptor Expressions in Brain Metastases from Breast Cancer: MRI-Based Non-Invasive Receptor Status Tracking.
Heitkamp A; Madesta F; Amberg S; Wahaj S; Schröder T; Bechstein M; Meyer L; Broocks G; Hanning U; Gauer T; Werner R; Fiehler J; Gellißen S; Kniep HC
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296843
[TBL] [Abstract][Full Text] [Related]
16. MRI-Based Radiomics for Preoperative Prediction of Lymphovascular Invasion in Patients With Invasive Breast Cancer.
Nijiati M; Aihaiti D; Huojia A; Abulizi A; Mutailifu S; Rouzi N; Dai G; Maimaiti P
Front Oncol; 2022; 12():876624. PubMed ID: 35734595
[TBL] [Abstract][Full Text] [Related]
17. Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain.
Jiaxin C; Jinmei Z; Huiqiang Z; Xuexue W; Xiaobo W; Shaohua Z; Yanhong T; Zefei J; Tao W
Front Neurol; 2022; 13():1002173. PubMed ID: 36353124
[TBL] [Abstract][Full Text] [Related]
18. Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results.
Leithner D; Horvat JV; Marino MA; Bernard-Davila B; Jochelson MS; Ochoa-Albiztegui RE; Martinez DF; Morris EA; Thakur S; Pinker K
Breast Cancer Res; 2019 Sep; 21(1):106. PubMed ID: 31514736
[TBL] [Abstract][Full Text] [Related]
19. Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status.
Hayashi N; Iwamoto T; Qi Y; Niikura N; Santarpia L; Yamauchi H; Nakamura S; Hortobagyi GN; Pusztai L; Symmans WF; Ueno NT
J Cancer; 2017; 8(6):1045-1052. PubMed ID: 28529618
[No Abstract] [Full Text] [Related]
20. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
